Profil
Lixian Jiang is currently the Chief Operating Officer & Vice President at Cz Biomed Corp.
Prior to this, he worked as the Chief Operating Officer at Stem Cell Therapy International, Inc. and as the Chief Operating Officer-China Division at AmStem Corp.
He holds a doctorate degree from the University of South Florida.
Aktive Positionen von Lixian Jiang
| Unternehmen | Position | Beginn |
|---|---|---|
Cz Biomed Corp.
Cz Biomed Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Geschäftsführer | - |
Ehemalige bekannte Positionen von Lixian Jiang
| Unternehmen | Position | Ende |
|---|---|---|
Stem Cell Therapy International, Inc.
Stem Cell Therapy International, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops stem cell transplantation therapy and regenerative medicine | Geschäftsführer | 09.02.2010 |
AmStem Corp.
AmStem Corp. Pharmaceuticals: OtherHealth Technology Researches and develops stem cell transplantation therapy and regenerative medicine | Corporate Officer/Principal | 09.02.2010 |
Ausbildung von Lixian Jiang
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of South Florida
University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stem Cell Therapy International, Inc.
Stem Cell Therapy International, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops stem cell transplantation therapy and regenerative medicine | Commercial Services |
AmStem Corp.
AmStem Corp. Pharmaceuticals: OtherHealth Technology Researches and develops stem cell transplantation therapy and regenerative medicine | Health Technology |
Cz Biomed Corp.
Cz Biomed Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
















